Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -3.10x is 81% above its 4-year average of -16.67x, near the low end of its 4-year range (-155.80x–445.67x).
As of the fiscal period ended Thursday, September 30, 2021. 103.49% below its 12-month average of 88.73x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2021 (2021-09-30): -3.10x.
INTEREST COVERAGE RATIO
-3.10x
INTEREST COVERAGE RATIO AVG TTM
88.73x
INTEREST COVERAGE RATIO AVG 3Y
12.86x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-103.49%
CURRENT VS 3Y AVG
-124.10%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+51.38%
vs the sector median at left
Yarrow Bioscience Inc
Market Cap
$177.71M
Interest Coverage Ratio
-3.10x
TTM Avg
88.73x
3Y Avg
12.86x
5Y Avg
N/A
Market Cap
$180.89M
Interest Coverage Ratio
N/A
TTM Avg
14.48x
3Y Avg
14.48x
5Y Avg
14.48x
Market Cap
$181.89M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$174.29M
Interest Coverage Ratio
-48.66x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$183.94M
Interest Coverage Ratio
-709.33x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$184.22M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$172.18M
Interest Coverage Ratio
-2.21x
TTM Avg
15.94x
3Y Avg
15.94x
5Y Avg
15.94x
Market Cap
$171.41M
Interest Coverage Ratio
-36.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$188.72M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Yarrow Bioscience Inc (YARW) | $177.71M | -3.10x | 88.73x | 12.86x | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $180.89M | N/A | 14.48x | 14.48x | 14.48x |
| Compass Therapeutics, Inc. (CMPX)vs › | $181.89M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $174.29M | -48.66x | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $183.94M | -709.33x | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $184.22M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $172.18M | -2.21x | 15.94x | 15.94x | 15.94x |
| Precision BioSciences, Inc. (DTIL)vs › | $171.41M | -36.67x | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $188.72M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $169.31M | -38.13x | 21.71x | 21.71x | 21.71x |
Interest Coverage
-3.1x
Debt/Equity
0.00
Current Ratio
15.26
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-09-30 | -3.10x |
| 2021-06-30 | -8.88x |
| 2021-03-31 | -9.19x |
| 2020-12-31 | 445.67x |
| 2020-09-30 | 19.16x |
| 2020-06-30 | -155.80x |
| 2020-03-31 | -37.21x |
| 2019-12-31 | -49.39x |
| 2019-09-30 | -30.52x |
| 2019-06-30 | -23.30x |
| 2018-12-31 | -5.97x |
| 2017-12-31 | -18.33x |
